The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

Giles Edmonds, Specsavers clinical services director, has emphasised the importance of community optometry’s support after ...

The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...

Optique Nashville, Tennessee’s premier destination for advanced eye care and medically necessary contact lenses, is proud to ...

The Union Budget 2026-27 has unveiled a comprehensive push to scale up India's AYUSH ecosystem, positioning traditional ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

Government to strengthen workforce, push care delivery outside hospitals, particularly in geriatric and allied health ...

Adit named a 2026 Gartner Digital Markets Leader, recognized across Capterra, Software Advice and GetApp for customer-rated performance.

Presenting the Union Budget, Finance Minister Nirmala Sitharaman said the move is aimed at strengthening India’s position as ...

The appointment comes after North Saanich failed to reach its first-year housing targets under the Housing Supply Act.

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...